Skip to content

Investors

Investors

Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:

Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.

Events & Presentations
Annual Report and Proxy Statement
Date Title and Summary
Toggle Summary Webcast Alert: Arena Pharmaceuticals Presentation at Informed Investors Healthcare Virtual Stocks Forum to be Webcast on Tuesday, August 17, 2004, 10:00 AM ET (7:00 AM PT)
Webcast Alert: Arena Pharmaceuticals Presentation at Informed Investors Healthcare Virtual Stocks Forum to be Webcast on Tuesday, August 17, 2004, 10:00 AM ET (7:00 AM PT) SAN DIEGO, Aug. 13 /PRNewswire/ -- Arena Pharmaceuticals (Nasdaq: ARNA) will present a corporate update at the following forum:
Toggle Summary USAN Council Approves Nonproprietary Name Lorcaserin Hydrochloride for Arena Drug Candidate APD356
USAN Council Approves Nonproprietary Name Lorcaserin Hydrochloride for Arena Drug Candidate APD356 SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the United States Adopted Names (USAN) Council has approved the nonproprietary name